The Phenotyping Study is the biggest effort we need to fund in 2018. This study will further define USP7-related diseases as a neurodevelopmental disorder and lead to more research.
Patients participating in the study will have a variety of tests performed such as, lab work, DEXA scan, lumbar puncture and more. Each patient participating will have to travel to Houston, TX.